Oligonucleotide Synthesis Market Size, Share and Global Trend By Products (Drugs, Probes, Linkers, Adapters, Reagents, Others), By Application (DNA Sequencing and Amplification (PCR), Detecting Complementary DNA or RNA Via Hybridization, Synthesis of Artificial Genes, Genetic Mutations, Others), By End User (Research Institutes, Diagnostic Laboratories, Pharmaceuticals Industries, Biotechnology Companies), and Regional Forecast, 2024-2032

Chemical synthesis of short fragments of nucleic acids is defined as oligonucleotide synthesis. Oligonucleotide synthesis provides many applications such a DNA sequencing, synthesis of artificial genes, and diagnostics of many diseases associated with a genetic mutation. Developments in oligonucleotide synthesis and growing research activities in synthetic as well as biology sector are some of the factors driving the global oligonucleotide synthesis market growth.

The more prominent use of DNA microarray technology with the use of oligonucleotide for diagnostics therapeutics and new microchip-based oligonucleotide synthesis has reduced the cost of synthesis of the oligonucleotide, and these factors are anticipated to boost the global oligonucleotide synthesis market growth during the projected period.

Oligonucleotide synthesis market growth is being driven by growing research activities, many strong pipeline candidates, and growing actuations and partnerships of may pharmaceutical companies and research institutes. For instance, in 2017, CordenPharma International signed an agreement with GE Healthcare Dharmacon Inc. for the development of an end-to-end oligonucleotide-based drug discovery solution. Also, reduction in the cost of sequencing and advent of novel techniques in oligonucleotide synthesis is anticipated to enhance the growth in oligonucleotide synthesis market during the forecast period.

However, the lack of funding in research and development sectors in the emerging nations is likely to hamper the oligonucleotide synthesis market growth during the forecast period.

Key Players Covered

Some of the major companies that are present in the global oligonucleotide synthesis market report include Agilent Technologies., ATDBio Ltd., Eurofins Genomics., Eurogentec., Genscript, Integrated DNA Technologies Inc., LGC Biosearch Technologies, Merck KGaA, Nitto Denko Avecia, Thermo Fisher Scientific and others.

SEGMENTATION

 As per the oligonucleotide synthesis market trends, oligonucleotide drugs among product segmentation are anticipated to hold the largest market share in the forecast period as they can target specific genes, which help in the development of personalized medicine.

Key Insights

• Overview of Advancement in Oligonucleotide Synthesis


• Overview of Pipeline Products


• Pricing Analysis


• The Regulatory Scenario for Key Countries/Regions


• Key Industry Developments –Mergers, Acquisitions, and Partnerships

Regional Analysis

The global oligonucleotide synthesis market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to dominate the global oligonucleotide synthesis market during the projected period owing to the emerging guidelines, high investments in research activities in the development of novel oligonucleotides, and growing adoption of novel technologies. In Asia Pacific the global oligonucleotide synthesis market is anticipated to grow at a significant rate during the forecast period owing to the growing demand of diagnostic tools and rising awareness of the emerging oligonucleotide synthesis technique by many research organizations.

Oligonucleotide Market Industry Developments

• In October 2018, DIA/FDA Oligonucleotide- based therapeutics conference was held in North Bethesda, that addressed on the quality risk management, manufacturing advances, specifications, formulation issues, oligonucleotide pharmacokinetics, nonclinical assessments in support of drug development and clinical advances in therapeutic targets, trial design and safety for antisense, siRNA, mRNA and microRNA therapies.
• In September 2018, 14th annual meeting of the Oligonucleotide Therapeutics Society took place in Seattle [providing data on the therapeutic applications of oligonucleotides.